Life Sciences Industry & Real Estate Perspective 2024

Putting Asia Pacific under the microscope

November 23, 2023

The life sciences sector in Asia Pacific is gaining momentum, buoyed by its strong fundamentals from demographic shifts to supportive government policies.

While 2022 witnessed a dip in investor appetite, there have been signs of a rebound this year, with more investors eyeing the specialised asset class for diversification and stability.

Historical challenges, such as limited data and market complexities, are gradually easing, creating new opportunities for capital deployment.

A particular bright spot for the thriving asset class is the future of life sciences clusters in the region.

The report delves into the region’s key clusters, exploring its investment metrics and key fundamentals behind their success such as the ecosystem, academic links, funding environment, infrastructure, and governmental policies.

Download our latest report to gain valuable insights on the life sciences industry.

Fill out this form to download report

There was an error submitting the form. Please try again.